Predominance of positive epistasis among drug resistance-associated mutations in HIV-1 protease
出版年份 2020 全文链接
标题
Predominance of positive epistasis among drug resistance-associated mutations in HIV-1 protease
作者
关键词
Fitness epistasis, Proteases, HIV-1, Viral replication, Viral evolution, HIV, Protease inhibitors, Deletion mutation
出版物
PLoS Genetics
Volume 16, Issue 10, Pages e1009009
出版商
Public Library of Science (PLoS)
发表日期
2020-10-22
DOI
10.1371/journal.pgen.1009009
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Constrained Mutational Sampling of Amino Acids in HIV-1 Protease Evolution
- (2019) Jeffrey I Boucher et al. MOLECULAR BIOLOGY AND EVOLUTION
- Epistasis and entrenchment of drug resistance in HIV-1 subtype B
- (2019) Avik Biswas et al. eLife
- Inference of Epistatic Effects Leading to Entrenchment and Drug Resistance in HIV-1 Protease
- (2017) William F. Flynn et al. MOLECULAR BIOLOGY AND EVOLUTION
- Clinical benefit of dolutegravir in HIV-1 management related to the high genetic barrier to drug resistance
- (2017) Bluma G. Brenner et al. VIRUS RESEARCH
- Local fitness landscape of the green fluorescent protein
- (2016) Karen S. Sarkisyan et al. NATURE
- Epistasis in protein evolution
- (2016) Tyler N. Starr et al. PROTEIN SCIENCE
- Adaptation in protein fitness landscapes is facilitated by indirect paths
- (2016) Nicholas C Wu et al. eLife
- Hepatitis C virus drug resistance-associated substitutions: State of the art summary
- (2015) Erik Lontok et al. HEPATOLOGY
- HIV-1 Resistance to the Capsid-Targeting Inhibitor PF74 Results in Altered Dependence on Host Factors Required for Virus Nuclear Entry
- (2015) Jing Zhou et al. JOURNAL OF VIROLOGY
- Deep Sequencing of Protease Inhibitor Resistant HIV Patient Isolates Reveals Patterns of Correlated Mutations in Gag and Protease
- (2015) William F. Flynn et al. PLoS Computational Biology
- Persistence of Transmitted HIV-1 Drug Resistance Mutations Associated with Fitness Costs and Viral Genetic Backgrounds
- (2015) Wan-Lin Yang et al. PLoS Pathogens
- A Comprehensive Biophysical Description of Pairwise Epistasis throughout an Entire Protein Domain
- (2014) C. Anders Olson et al. CURRENT BIOLOGY
- A Systematic Survey of an Intragenic Epistatic Landscape
- (2014) Claudia Bank et al. MOLECULAR BIOLOGY AND EVOLUTION
- Strong Epistatic Interactions within a Single Protein
- (2014) Mariona Parera et al. MOLECULAR BIOLOGY AND EVOLUTION
- Molecular mechanisms of antibiotic resistance
- (2014) Jessica M. A. Blair et al. NATURE REVIEWS MICROBIOLOGY
- High-throughput profiling of point mutations across the HIV-1 genome
- (2014) Laith Q Al-Mawsawi et al. Retrovirology
- A Quantitative High-Resolution Genetic Profile Rapidly Identifies Sequence Determinants of Hepatitis C Viral Fitness and Drug Sensitivity
- (2014) Hangfei Qi et al. PLoS Pathogens
- Translating HIV Sequences into Quantitative Fitness Landscapes Predicts Viral Vulnerabilities for Rational Immunogen Design
- (2013) Andrew L. Ferguson et al. IMMUNITY
- Viral fitness cost prevents HIV-1 from evading dolutegravir drug pressure
- (2013) Thibault Mesplède et al. Retrovirology
- Antiretroviral dynamics determines HIV evolution and predicts therapy outcome
- (2012) Daniel I S Rosenbloom et al. NATURE MEDICINE
- The distinct contributions of fitness and genetic barrier to the development of antiviral drug resistance
- (2012) Matthias Götte Current Opinion in Virology
- Strain diversity, epistasis and the evolution of drug resistance in Mycobacterium tuberculosis
- (2011) S. Borrell et al. CLINICAL MICROBIOLOGY AND INFECTION
- Accessory Mutations Maintain Stability in Drug-Resistant HIV-1 Protease
- (2011) Max W. Chang et al. JOURNAL OF MOLECULAR BIOLOGY
- A systems analysis of mutational effects in HIV-1 protease and reverse transcriptase
- (2011) Trevor Hinkley et al. NATURE GENETICS
- Negative Epistasis Between Beneficial Mutations in an Evolving Bacterial Population
- (2011) A. I. Khan et al. SCIENCE
- Pervasive Sign Epistasis between Conjugative Plasmids and Drug-Resistance Chromosomal Mutations
- (2011) Rui F. Silva et al. PLoS Genetics
- HIV-1 Protease Mutations and Protease Inhibitor Cross-Resistance
- (2010) S.-Y. Rhee et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Compensation of Fitness Costs and Reversibility of Antibiotic Resistance Mutations
- (2010) P. Schulz zur Wiesch et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Antibiotic resistance and its cost: is it possible to reverse resistance?
- (2010) Dan I. Andersson et al. NATURE REVIEWS MICROBIOLOGY
- Epistasis among Deleterious Mutations in the HIV-1 Protease
- (2009) Mariona Parera et al. JOURNAL OF MOLECULAR BIOLOGY
- Positive Epistasis Drives the Acquisition of Multidrug Resistance
- (2009) Sandra Trindade et al. PLoS Genetics
- Resistance Profile of Darunavir: Combined 24-Week Results from the POWER Trials
- (2008) Sandra de Meyer et al. AIDS RESEARCH AND HUMAN RETROVIRUSES
- Second generation HIV protease inhibitors against resistant virus
- (2008) Zhijian Lu Expert Opinion on Drug Discovery
- Transmission of HIV-1 Gag immune escape mutations is associated with reduced viral load in linked recipients
- (2008) Paul A. Goepfert et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Minority HIV-1 Drug Resistance Mutations Are Present in Antiretroviral Treatment–Naïve Populations and Associate with Reduced Treatment Efficacy
- (2008) Jeffrey A Johnson et al. PLOS MEDICINE
- Drug resistance in HIV-1 protease: Flexibility-assisted mechanism of compensatory mutations
- (2002) Stefano Piana et al. PROTEIN SCIENCE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search